Abeona Therapeutics, Inc. (ABEO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$6.00+1.18%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ABEO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 5.8 | 4.2 | 3.5 | 1.4 | 3.0 | 10.0 | 3.0 | 3.0 | 0.8 | 0.9 | 1.0 | 0.9 | 2.0 | 4.4 | 1.8 |
| Total Revenues | — | — | — | — | — | — | — | — | 3.0 | 0.8 | 0.9 | 1.0 | 0.9 | 2.0 | 4.4 | 1.8 |
| Cost of Revenues | — | 1.5 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 73.4 | 65.0 | — | — | — | — | — | — | — | — | — | — | 3.7 | 4.8 | 6.0 | — |
| R&D Expenses | 25.5 | 26.8 | 34.4 | 31.1 | 29.0 | 38.7 | 30.1 | 48.6 | 38.7 | 17.0 | 10.7 | 4.7 | 0.3 | 0.9 | 2.0 | 3.6 |
| Operating Income | (83.6) | (89.4) | (64.2) | (47.1) | (50.9) | (89.8) | (81.4) | (77.1) | (58.2) | (27.8) | (23.9) | (18.5) | (3.1) | (3.8) | (4.3) | (7.9) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 3.3 | 3.7 | 4.2 | 0.4 | 0.7 | 3.7 | 4.1 | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | 1.5 | 0.5 | 2.0 | 4.0 | 0.0 | 0.3 | 0.2 | 1.3 |
| Other Non-Operating Income / Expenses | 0.2 | 0.4 | 1.2 | 2.9 | 0.1 | — | — | — | — | 0.5 | 2.0 | 4.0 | (23.6) | 8.3 | (6.2) | 5.4 |
| Asset Writedown | — | — | — | — | 1.8 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (78.3) | 71.3 | — | — | — | — | — | — | — | — | — | — | — | — | (10.5) | (2.5) |
| Income Tax Expense | — | 0.1 | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (205.3) | 71.2 | (63.7) | 54.2 | (39.7) | (84.9) | (84.2) | (76.3) | (56.7) | (27.3) | (21.9) | (14.5) | (26.8) | 4.4 | (10.5) | (2.5) |
| Per Share | ||||||||||||||||
| Basic EPS | (3.60) | 1.34 | (1.55) | (2.53) | (5.53) | (21.57) | — | — | — | — | — | — | (15.26) | 3.07 | — | — |
| Diluted EPS | (3.60) | 1.01 | (1.55) | (2.53) | (5.53) | — | — | — | — | — | — | — | (15.26) | 3.04 | — | — |
| Basic Weighted Avg Shares | 57.0 | 53.0 | 41.0 | 21.4 | 7.9 | 3.9 | — | — | — | — | 34.2 | 27.6 | 1.9 | 0.5 | — | — |
| Diluted Weighted Avg Shares | 57.0 | 66.1 | 41.0 | 21.4 | 7.9 | — | — | — | — | — | — | — | 1.9 | 0.5 | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (86.9) | (62.2) | (44.8) | (47.8) | (86.5) | (78.2) | (74.5) | (57.0) | (27.6) | (23.7) | (18.5) | (3.1) | (3.8) | (4.3) | (7.6) |
| EBIT | (83.6) | (89.4) | (64.2) | (47.1) | (50.9) | (89.8) | (81.4) | (77.1) | (58.2) | (27.8) | (23.9) | (18.5) | (3.1) | (3.8) | (4.3) | (7.9) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0% | -0.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.